| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,572 |
5,199 |
$446K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,264 |
6,681 |
$422K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,002 |
11,061 |
$350K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,984 |
3,629 |
$274K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,473 |
2,990 |
$69K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
431 |
404 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,249 |
3,110 |
$37K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
693 |
646 |
$36K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
407 |
393 |
$11K |
| 87400 |
|
299 |
284 |
$6K |
| 87807 |
|
348 |
323 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$410.67 |
| 81003 |
|
206 |
197 |
$340.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
15 |
$159.79 |
| 99000 |
|
16 |
15 |
$0.00 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.00 |
| 99072 |
|
768 |
712 |
$0.00 |